Trials / Unknown
UnknownNCT04931524
A Study to Assess the Absorption, Metabolism and Excretion of [14C]-ANG-3777
An Open Label, Single-Dose Study to Assess the Mass Balance Recovery, Metabolism and Excretion of [14C] ANG 3777 in Healthy Male Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Angion Biomedica Corp · Industry
- Sex
- Male
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the mass balance recovery and metabolic profiling and identification of 14C-ANG-3777 administered as a single IV dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | carbon-14-[14C]-ANG-3777 | Arms assigned to this intervention will receive 240 mg, IV and not more than 5.2 MBq, Fasted |
Timeline
- Start date
- 2021-05-21
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2021-06-18
- Last updated
- 2021-06-18
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04931524. Inclusion in this directory is not an endorsement.